FOR IMMEDIATE RELEASE
For more information:
HealthBridge Management LLC
DR. GINA PUBLISHES PEER REVIEWED RESEARCH ARTICLE
ON KEY NUTRACEUTICALS
A new peer reviewed article entitled “Primary Risks of Oral Contraceptives
and HRT” discusses the benefits of two nutraceuticals- BRM4 and Plasmanex1, manufactured by Daiwa Pharmaceuticals, and
researched by Dr. Gina Cushman in clinical practice.
(Newport Beach, CA) May 3, 2012- Gina Cushman, NMD,
PhD, owner and founder of HealthBridge Medical Center and HealthBridge Management LLC in Newport Beach, CA has just
been published in the peer reviewed Natural Medicine Journal, the official journal of the American Association of Naturopathic
Physicians. She discusses ways to offset the primary risks that women face when taking hormone replacement therapy (HRT) and
oral contraceptives (OC) prescribed by their physicians, including the use of 2 natural food extracts--Plasmanex1 and BRM4--one
showing anticoagulant effects and the other exhibiting certain anti-inflammatory and immunomodulatory effects. Her discussion
is based on the results of a clinical research study on the extracts, that was led by Dr. Cushman at her medical practice,
and presented worldwide at three PharmCon peer-reviewed continuing medical education events on June 9th, 2011; July 7th, 2011; and August 10th, 2011.
am pleased to see that our team at HealthBridge was able to research these nutraceuticals in a real world medical practice
setting, identifying a new and important application for the products, and then share the results of our research with thousands
of physicians and pharmacists worldwide, through continuing medical education seminars and now through publication in a reputable
peer-reviewed journal, “ says Dr. Cushman.
Long-term use of OCs and HRT have been
linked to increased risks of cardiovascular problems, and chronic immune disorders with an inflammatory component, including
cancer. The research study designed and led by Dr. Cushman investigated the clinical effects of the use of BRM4 (also
referred to as BioBran, MGN3 or RBAC in some countries) and Plasmanex1 (NKCP) for the purpose of uncovering potential benefits
of combined use, as well as areas that may prove fruitful for further research into ways to prevent serious side effects from
OCs/HRT. The 6-week private practitioner research study included case study results that demonstrated the significant impact
of these 2 extracts—Plasmanex1 and BRM4—on OC users and HRT users, with regard to offsetting thrombotic risk and
improving inflammatory symptoms.
Reference: Cushman, G. Primary Risks of Oral Contraceptives and
HRT. Nat Med Journal. May 1, 2012. http://naturalmedicinejournal.com/article_content.asp?edition=1§ion=2&article=321
# # #
About HealthBridge Management LLC
HealthBridge Management LLC is a nationally
recognized consulting firm specializing in medical marketing, sales and distribution for the pharmaceutical and nutraceutical
industries. HealthBridge delivers simple, affordable and doable medical sales, research and marketing solutions to meet
the need, worldwide, for quality education, and access to effective pharmaceutical and nutraceutical products. For further
information on our firm, partial client list and client comments, please visit www.HealthBridge.tv or call 949.612.9890.